Notes
2014 US dollars
Reference
Michaud K, et al. Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis. Rheumatology : 15 Apr 2015. Available from: URL: http://doi.org/10.1093/rheumatology/kev023
Rights and permissions
About this article
Cite this article
Multibiomarker disease activity test cost saving in RA. PharmacoEcon Outcomes News 727, 23 (2015). https://doi.org/10.1007/s40274-015-2107-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2107-9